JP2022530837A5 - - Google Patents

Info

Publication number
JP2022530837A5
JP2022530837A5 JP2021565092A JP2021565092A JP2022530837A5 JP 2022530837 A5 JP2022530837 A5 JP 2022530837A5 JP 2021565092 A JP2021565092 A JP 2021565092A JP 2021565092 A JP2021565092 A JP 2021565092A JP 2022530837 A5 JP2022530837 A5 JP 2022530837A5
Authority
JP
Japan
Prior art keywords
composition according
eye
hyaluronic acid
eye composition
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021565092A
Other languages
English (en)
Japanese (ja)
Other versions
JP7334266B2 (ja
JP2022530837A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/030691 external-priority patent/WO2020227002A1/en
Publication of JP2022530837A publication Critical patent/JP2022530837A/ja
Publication of JP2022530837A5 publication Critical patent/JP2022530837A5/ja
Application granted granted Critical
Publication of JP7334266B2 publication Critical patent/JP7334266B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021565092A 2019-05-03 2020-04-30 眼疾患治療用の組成物および方法 Active JP7334266B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962842995P 2019-05-03 2019-05-03
US62/842,995 2019-05-03
PCT/US2020/030691 WO2020227002A1 (en) 2019-05-03 2020-04-30 Compositions and methods for treatment of ocular diseases

Publications (3)

Publication Number Publication Date
JP2022530837A JP2022530837A (ja) 2022-07-01
JP2022530837A5 true JP2022530837A5 (https=) 2023-05-12
JP7334266B2 JP7334266B2 (ja) 2023-08-28

Family

ID=70861542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021565092A Active JP7334266B2 (ja) 2019-05-03 2020-04-30 眼疾患治療用の組成物および方法

Country Status (9)

Country Link
US (2) US11376214B2 (https=)
EP (1) EP3962452A1 (https=)
JP (1) JP7334266B2 (https=)
KR (2) KR102649858B1 (https=)
CN (1) CN114025742A (https=)
CA (1) CA3139060A1 (https=)
IL (1) IL287802B2 (https=)
MX (1) MX2021013447A (https=)
WO (1) WO2020227002A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10945858B2 (en) * 2010-09-03 2021-03-16 Globus Medical, Inc. Expandable interspinous process fixation device
GB202008857D0 (en) * 2020-06-11 2020-07-29 Univ Birmingham Fluid gel compositions
GB202008853D0 (en) * 2020-06-11 2020-07-29 Univ Birmingham Fluid gel compositions
CN112587475B (zh) * 2020-12-18 2022-09-13 华熙生物科技股份有限公司 一种载药凝胶及其制备方法
DE102023116924A1 (de) * 2023-06-27 2025-01-02 Carl Zeiss Meditec Ag Kit zur Verwendung in einer Augenoperation und ophthalmische viskoelastische Vorrichtung
WO2025155730A1 (en) * 2024-01-16 2025-07-24 Regents Of The University Of Minnesota Injectable hydrogel for embolization

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE312076T1 (de) * 2001-02-22 2005-12-15 Anika Therapeutics Inc Thiol-modifizierte hyaluronan-derivate
CA2703807C (en) * 2010-05-12 2017-10-24 Molly S. Shoichet Enhanced stability of inverse thermal gelling composite hydrogels
US10137199B2 (en) * 2013-05-14 2018-11-27 Biotime, Inc. Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione
US9782345B2 (en) * 2013-10-17 2017-10-10 Jade Therapeutics, Inc. Ocular composition and method
EP3675873A4 (en) * 2017-09-01 2021-06-16 Pmidg, Llc Functionalized and crosslinked polymers
US12029753B2 (en) * 2017-09-19 2024-07-09 The Hong Kong University Of Science And Technology Biocompatible material and methods for making and using thereof

Similar Documents

Publication Publication Date Title
JP2022530837A5 (https=)
Burgalassi et al. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes
CN107362157B (zh) 用于医学和兽医学的眼科药物组合物
JP2004262777A (ja) アセチル化ヒアルロン酸含有眼用医薬組成物
DK2373321T3 (en) Biovedhæftende platelet lysate and compositions thereof for the treatment of mucostitis
TWI898399B (zh) 含有迪夸弗索(Diquafosol)及陽離子性聚合物之眼科用組合物
TWI848171B (zh) 含有迪夸弗索(diquafosol)或其鹽、及聚乙烯吡咯烷酮之水性眼科用組合物
TW200303749A (en) Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
TW201808289A (zh) 含阿托平之水性組成物
RS54815B1 (sr) Supstanca koja sadrži antibiotik i disperzant
JP5571673B2 (ja) 粘液様の組成物およびその使用
EP2839830B1 (en) Kits and compositions for treating lower urinary tract disorders
JP2002528518A (ja) 粘液付着性ポリマー、その使用およびその製造法
ES2994624T3 (en) Ophthalmic composition containing diquafosol or salt thereof, vinyl-based polymer and cellulose-based polymer
WO2014152790A1 (en) Chelated drug delivery systems
ES2324118T3 (es) Composicion farmaceutica sin dexpantenol, iones calcio y fosfato asi como uso de quelantes de calcio y regulador de la viscosidad oftalmologicamente compatible.
CN112105320A (zh) 治疗近视进展
CN101972224B (zh) 一种眼用原位凝胶
JP2001501194A (ja) ゲル形成性医薬組成物
US20190000983A1 (en) An eye drop solution for enhanced hyaluronic acid retention and delivery
KR101840256B1 (ko) 레바미피드를 함유하는 새로운 안구건조증 치료용 점안 조성물 및 이의 가용화 및 안정화 방법
JP2018532798A (ja) 耳の疾患および障害の処置におけるジベンゾアゼピン化合物およびその使用
JP6817300B2 (ja) 滅菌水性点眼液の治療的使用
JP2671381B2 (ja) 点眼剤
TW202320835A (zh) 用於治療或抑制細胞損失之組氨素組合及方法